Electrocardiographic criteria in founder mutations related to Arrhythmogenic cardiomyopathy
Article Sidebar
Main Article Content
Article Details
Copyright (c) 2018 Peters S.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Journal of Cardiology and Cardiovascular Medicine is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Cardiology and Cardiovascular Medicine is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Abdel Wahab A, Gardner M, Parkash R, Gray C, Sapp J. Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations. J Cardiovasc Electrophysiol 2018; 29: 90-97. Ref.: https://goo.gl/479Nom
Milting H, Klauke B, Christensen AH, Müsebeck J, Walhorn V, et al. The TMEM43 Newfoundland mutation p.S358L causing AVRC-5 was imported from Europe and increases the stiffness of the cell nucleus. Eur Heart J 2015; 36: 872-881. Ref.: https://goo.gl/5nuLE3
Van Rijsingen IA, van der Zwaag PA, Groeneweg JA, Nannenberg FA, Jongbloed JD, et al. Outcome in phospholamban R14del carriers: results of a large multicentre cohort study. Circ Cardiovasc Genet. 2014; 7: 455-465. Ref.: https://goo.gl/dxya6v
Hodgkinson KA, Connors SP, Merner N, Haywood A, Young TL, et al. The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43. Clin Genet. 2013; 83: 321-331. Ref.: https://goo.gl/ec7JiK
Groeneweg JA, van der Zwaag PA, Olde Nordkamp LR, Bikker H, Jongbloed JD, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers. Am J Cardiol. 2013; 112: 1197-1206. Ref.: https://goo.gl/xLgKxQ
Zhang L, Liu L, Kowey PR, Fontaine GH. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014; 10: 237-245. Ref.: https://goo.gl/vgyvwm
Peters S. Prognostic value of epsilon waves in lead AVR in arrhythmogenic cardiomyopathy. Int J Cardiol. 2015; 191: 77-78. Ref.: https://goo.gl/7WA3Wm
Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missence mutation in the TMEM43 gene. Am J Hum Genet. 2008; 82: 809-821. Ref.: https://goo.gl/sbrfH2
Sepehrkhony S, Gho JMIH, van Es R, Harakalova M, de Jonge N, et al. Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies. Heart Rhythm. 2017; 14: 1024-1032. Ref.: https://goo.gl/MfCGfc
Peters S. Clinical importance of lead aVR in arrhythmogenic cardiomyopathy. Int J Cardiol. 2014; 176: 508-509. Ref.: https://goo.gl/x8788E
Peters S. Low amplitude of inverted T-waves in lead aVR characterise patients with arrhythmogenic cardiomyopathy. Int J Cardiol. 2016; 220: 202. Ref.: https://goo.gl/HLNytQ